BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017 No. 1114 URL: http://www.bailii.org/uk/legis/num_reg/2017/uksi_20171114_en_1.html |
||
[New search] [Printable PDF version] [Help]
Statutory Instruments
Dangerous Drugs
Made
15th November 2017
Coming into force
27th November 2017
At the Court at Buckingham Palace, the 15th day of November 2017
Present,
The Queen's Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971(1) a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
1. This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017 and comes into force on the 27th November 2017.
2. The following amendment is made to Schedule 2 to the Misuse of Drugs Act 1971.
3. In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs) after "Methylphenobarbitone" insert-
"N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA).".
Ceri King
Deputy Clerk of the Privy Council
(This note is not part of the Order)
This Order brings certain drugs under the control of the Misuse of Drugs Act 1971 (‘the Act'). Article 3 of this Order brings methiopropamine or MPA related materials under permanent control as Class B drugs under the Act. These methiopropamine or MPA related materials were specified under section 2A of the Act as drugs subject to temporary control by virtue of the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2016 (S.I. 2016/1126) and cease to be subject to such temporary control on the coming into force of this Order in accordance with section 2A(6)(b) of the Act.
1971 c. 38. Schedule 2 has been amended by section 21 of the Drugs Act 2005 (c. 17) and S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589, 1995/1966, 1996/1300, 1998/750, 2001/3932, 2003/1243, 2003/3201, 2005/3178, 2006/3331, 2008/3130, 2009/3209, 2010/1207, 2010/1833, 2011/744, 2012/1390, 2013/239, 2014/1106, 2014/1352, 2014/3271, 2015/215, 2016/1109 and 2017/634.
